Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Initiation of semaglutide for weight management during the study period.
Age more than or equal to (≥) 18 at treatment initiation
Baseline body mass index (BMI) ≥27 and less than (\<) 30 kilogram per meter square (kg/m\^2) with at least one weight-related comorbidity, or BMI ≥30 kg/m\^2.
You may not be if
Prior use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) based medication or other obesity management medication (OMMs).
Bariatric surgery at baseline.
Diabetes at baseline.
Pregnancy at baseline.
Clareo Health | Weight Loss in Adults Using Semaglutide (Real-world Study)
